Description

Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.

Figure 56

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 56: Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy." />
  <figcaption>Figure 56. Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études